Performance of AZN AstraZeneca PLC | 3.3% in 12m
Compare AZN with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare AstraZeneca PLC with its related Sector/Index XLV
Performance Duell AZN vs XLV
| TimeFrame | AZN | XLV |
|---|---|---|
| 1 Day | -0.87% | 0.25% |
| 1 Week | 0.22% | 0.28% |
| 1 Month | 13.5% | -1.67% |
| 3 Months | 18.1% | -0.77% |
| 6 Months | 19.1% | 10.69% |
| 12 Months | 3.32% | 7.15% |
| YTD | 13.5% | 1.84% |
| Rel. Perf. 1m | 1.45 | |
| Rel. Perf. 3m | 1.25 | |
| Rel. Perf. 6m | 0.48 | |
| Rel. Perf. 12m | -0.39 |
Is AstraZeneca PLC a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, AstraZeneca PLC (LSE:AZN) is currently (May 2024)
ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 42.20 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AZN as of May 2024 is 12258.23. This means that AZN is currently overvalued and has a potential downside of 1.73% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AZN as of May 2024 is 12258.23. This means that AZN is currently overvalued and has a potential downside of 1.73% (Sold with Premium).
Is AZN a buy, sell or hold?
AstraZeneca PLC has no consensus analysts rating. ValueRay therefore judges the recommendation based on the last 12 Month Returns of 3.32%.
In compare to Health Care Sector SPDR Fund, AZN made -3.83% less over the last 12 months. Due to the underperformance, it is recommend to sell AZN.
In compare to Health Care Sector SPDR Fund, AZN made -3.83% less over the last 12 months. Due to the underperformance, it is recommend to sell AZN.
Values above 0%: AZN is performing better - Values below 0%: AZN is underperforming
Compare AZN with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -0.02% | 14.85% | 0.91% | -22.38% |
| US NASDAQ 100 | QQQ | -0.41% | 14.60% | 0.70% | -32.45% |
| US Dow Jones Industrial 30 | DIA | -0.55% | 13.96% | 4.63% | -13.76% |
| German DAX 40 | DBXD | 0.90% | 14.41% | 0.40% | -9.05% |
| UK FTSE 100 | ISFU | -0.59% | 9.87% | 5.15% | -5.43% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -1.59% | 9.45% | 16.62% | 13.96% |
| Hongkong Hang Seng | HSI | -3.84% | 5.28% | 20.64% | 17.94% |
| Japan Nikkei 225 | EXX7 | -1.51% | 16.45% | 4.36% | -15.32% |
| India NIFTY 50 | INDA | -0.16% | 12.11% | -0.23% | -24.29% |
| Brasil Bovespa | EWZ | -1.54% | 11.90% | 14.62% | -15.88% |
AZN AstraZeneca PLC vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -1.08% | 16.27% | -0.56% | -35.47% |
| Consumer Discretionary | XLY | 1.38% | 13.99% | 7.76% | -18.49% |
| Consumer Staples | XLP | 0.15% | 11.38% | 7.25% | 2.13% |
| Energy | XLE | 4.18% | 19.09% | 9.16% | -16.05% |
| Financial | XLF | 0.74% | 15.92% | -2.35% | -24.34% |
| Health Care | XLV | -0.06% | 15.14% | 8.41% | -3.83% |
| Industrial | XLI | 0.79% | 15.78% | -3.10% | -22.13% |
| Materials | XLB | 1.04% | 16.96% | 3.69% | -11.38% |
| Real Estate | XLRE | -0.19% | 17.01% | 10.33% | 0.91% |
| Technology | XLK | -0.71% | 15.36% | 1.49% | -31.70% |
| Utilities | XLU | -1.75% | 8.48% | 6.26% | 0.81% |
| Aerospace & Defense | XAR | -1.35% | 12.36% | 2.59% | -20.76% |
| Biotech | XBI | -5.00% | 13.69% | -9.68% | -2.09% |
| Homebuilder | XHB | -0.49% | 16.57% | -19.04% | -46.60% |
| Retail | XRT | -0.08% | 15.14% | -0.97% | -18.44% |
Does AstraZeneca PLC outperform its market, is AZN a Sector Leader?
No, over the last 12 months AstraZeneca PLC (AZN) made 3.32%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 7.15%.
Over the last 3 months AZN made 18.14%, while XLV made -0.77%.
No, over the last 12 months AstraZeneca PLC (AZN) made 3.32%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 7.15%.
Over the last 3 months AZN made 18.14%, while XLV made -0.77%.
| Period | AZN | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 13.47% | -1.67% | -1.38% |
| 3 Months | 18.14% | -0.77% | 4.13% |
| 12 Months | 3.32% | 7.15% | 25.70% |